| List | Section | Observation |
|---|---|---|
| Barbados. Barbados National Drug Formulary (BNDF) | 20.16 Hematopoietic Agents | No observations |
| List | Section | Observation |
|---|---|---|
| Barbados. Barbados National Drug Formulary (BNDF) | 20.16 Hematopoietic Agents | No observations |
| List | Section | Observation |
|---|---|---|
| Barbados. Barbados National Drug Formulary (BNDF) | 20.16 Hematopoietic Agents | No observations |
| List | Section | Observation |
|---|---|---|
| Barbados. Barbados National Drug Formulary (BNDF) | 20.16 Hematopoietic Agents | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.1. Antianaemia medicines |
This medicine has the best evidence for effectiveness and safety. |
| Haiti. National List of Essential Medicines | 10.01 Antianaemics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.1. Antianaemia medicines |
This medicine has the best evidence for effectiveness and safety. |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.1. Antianaemia medicines |
This medicine has the best evidence for effectiveness and safety. |
| Haiti. National List of Essential Medicines | 10.01 Antianaemics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.1. Antianaemia medicines |
This medicine has the best evidence for effectiveness and safety. |
| Haiti. National List of Essential Medicines | 10.01 Antianaemics | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 20.16 Hematopoietic Agents | No observations |
| List | Section | Observation |
|---|---|---|
| Barbados. Barbados National Drug Formulary (BNDF) | 20.16 Hematopoietic Agents | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.1. Antianaemia medicines |
This medicine has the best evidence for effectiveness and safety. |
| Haiti. National List of Essential Medicines | 10.01 Antianaemics | No observations |
| List | Section | Observation |
|---|---|---|
| Haiti. National List of Essential Medicines | 10.01 Antianaemics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.1. Antianaemia medicines |
This medicine has the best evidence for effectiveness and safety. |
| Haiti. National List of Essential Medicines | 10.01 Antianaemics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.1. Antianaemia medicines |
This medicine has the best evidence for effectiveness and safety. |
| Haiti. National List of Essential Medicines | 10.01 Antianaemics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.1. Antianaemia medicines |
This medicine has the best evidence for effectiveness and safety. |
| Haiti. National List of Essential Medicines | 10.01 Antianaemics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.1. Antianaemia medicines |
This medicine has the best evidence for effectiveness and safety. |
| Haiti. National List of Essential Medicines | 10.01 Antianaemics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.1. Antianaemia medicines |
This medicine has the best evidence for effectiveness and safety. |
| Haiti. National List of Essential Medicines | 10.01 Antianaemics | No observations |